Sofalcone, a mucoprotective agent, increases the cure rate of Helicobacter pylori infection when combined with rabeprazole, amoxicillin and clarithromycin

AIM: The mucoprotective agents, sofalcone and polaprezinc have anti-Helicobacter pylori (H pylori) activities. We determined the therapeutic effects of sofalcone and polaprezinc when combined with rabeprazole, amoxicillin and clarithromycin for Helicobacter pylori infection. METHODS: One hundred and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Isomoto, Hajime, Furusu, Hisashi, Ohnita, Ken, Wen, Chun-Yang, Inoue, Kenichiro, Kohno, Shigeru
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2005
Matèries:
Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305943/
https://ncbi.nlm.nih.gov/pubmed/15786539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v11.i11.1629
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars